Albumin is the main nucleophilic target of human plasma: A protective role against pro-atherogenic electrophilic reactive carbonyl species?

Chemical Research in Toxicology

Volumn 21, Issue 4, 2008, Pages 824-835

  Aldini, Giancarlo ^a   Vistoli, Giulio ^a   Regazzoni, Luca ^a   Gamberoni, Luca ^a   Facino, Roberto Maffei ^a   Yamaguchi, Satoru ^b   Uchida, Koji ^b   Carini, Marina ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; REACTIVE CARBONYL SPECIES; REACTIVE OXYGEN METABOLITE; SCHIFF BASE;

ARTICLE; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR WEIGHT; PROTEIN TARGETING; PROTEOMICS; STATISTICAL SIGNIFICANCE;

ADULT; ALDEHYDES; ATHEROSCLEROSIS; CYSTEINE; HUMANS; LYSINE; PEPTIDES; PROTECTIVE AGENTS; SERUM ALBUMIN;

EID: 43149094897     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx700349r     Document Type: Article

References (62)

1. Uchida, K. (2000) Role of reactive aldehyde in cardiovascular diseases. Free Radical Biol. Med. 28, 1685-1696.
2. Leonarduzzi, G., Chiarpotto, E., Biasi, F., and Poli, G. (2005) 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol. Nutr. Food Res. 49, 1044-1049.
3. Poli, G., and Schaur, R. J. (2000) 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 50, 315-321.
4. Uchida, K. (2000) Role of reactive aldehyde in cardiovascular diseases. Free Radical Biol. Med. 28, 1685-1696.
5. Berliner, J., and Heinecke, J. W. (1996) The role of oxidized lipoproteins in atherogenesis. Free Radical Biol. Med. 20, 707-727.
6. Vindis, C., Escargueil-Blanc, I., Elbaz, M., Marcheix, B., Grazide, M. H., Uchida, K., Salvayre, R., and Negre-Salvayre, A. (2006) Desensitization of platelet-derived growth factor receptor-beta by oxidized lipids in vascular cells and atherosclerotic lesions: Prevention by aldehyde scavengers. Circ. Res. 98, 785-792.
7. Tamamizu-Kato, S., Wong, J. Y., Jairam, V., Uchida, K., Raussens, V., Kato, H., Ruysschaert, J. M., and Narayanaswami, V. (2007) Modification by acrolein, a component of tobacco smoke and age-related oxidative stress, mediates functional impairment of human apolipoprotein E. Biochemistry 46, 8392-8400.
8. Ellis, E. M. (2007) Reactive carbonyls and oxidative stress: Potential for therapeutic intervention. Pharmacol. Ther. 115, 13-24.
9. Yang, Y., Yang, Y., Trent, M. B., He, N., Lick, S. D., Zimniak, P., Awasthi, Y. C., and Boor, P. J. (2004) Glutathione-S-transferase A4-4 modulates oxidative stress in endothelium: Possible role in human atherosclerosis. Atherosclerosis 173, 211-221.
10. Takagi, S., Iwai, N., Yamauchi, R., Kojima, S., Yasuno, S., Baba, T., Terashima, M., Tsutsumi, Y., Suzuki, S., Morii, I., Hanai, S., Ono, K., Baba, S., Tomoike, H., Kawamura, A., Miyazaki, S., Nonogi, H., and Goto, Y. (2002) Aldehyde dehydrogenase 2 gene is a risk factor for myocardial infarction in Japanese men. Hypertens. Res. 25, 677-681.
11. Srivastava, S., Dixit, B. L., Cai, J., Sharma, S., Hurst, H. E., Bhatnagar, A., and Srivastava, S. K. (2000) Metabolism of lipid peroxidation product, 4-hydroxynonenal (HNE) in rat erythrocytes: Role of aldose reductase. Free Radical Biol. Med. 29, 642-651.
12. Michelet, F., Gueguen, R., Leroy, P., Wellman, M., Nicolas, A., and Siest, G. (1995) Blood and plasma glutathione measured in healthy subjects by HPLC: Relation to sex, aging, biological variables, and life habits. Clin. Chem. 41, 1509-1517.
13. Dockham, P. A., Sreerama, L., and Sladek, N. E. (1997) Relative contribution of human erythrocyte aldehyde dehydrogenase to the systemic detoxification of the oxazaphosphorines. Drug Metab. Dispos. 25, 1436-1441.
14. Uchida, K., Osawa, T., Hiai, H., and Toyokuni, S. (1995) 4-Hydroxy-2-nonenal-trapping ELISA: Direct evidence for the release of a cytotoxic aldehyde from oxidized low density lipoproteins. Biochem. Biophys. Res. Commun. 212, 1068-1073.
15. Alary, J., Bravais, F., Cravedi, J. P., Debrauwer, L., Rao, D., and Bories, G. (1995) Mercapturic acid conjugates as urinary end metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in the rat. Chem. Res. Toxicol. 8, 34-39.
16. Rees, M. S., van Kuijk, F. J., Siakotos, A. N., and Mundy, B. P. (1995) Improved synthesis of various isotope-labelled 4-hydroxyalkenals and peroxidation intermediates. Synth. Commun. 25, 3225-2236.
17. Bar-Or, D., Heyborne, K. D., Bar-Or, R., Rael, L. T., Winkler, J. V., and Navot, D. (2005) Cysteinylation of maternal plasma albumin and its association with intrauterine growth restriction. Prenatal Diagn. 25, 245-249.
18. Glowacki, R., and Jakubowski, H. (2004) Cross-talk between Cys34 and lysine residues in human serum albumin revealed by N-homocysteinylation. J. Biol. Chem. 279, 10864-10871.
19. Aldini, G., Gamberoni, L., Orioli, M., Beretta, G., Regazzoni, L., Maffei Facino, R., and Carini, M. (2006) Mass spectrometric characterization of covalent modification of human serum albumin by 4-hydroxy-trans-2- nonenal. J. Mass Spectrom. 41, 1149-1161.
20. Riener, C. K., Kada, G., and Gruber, H. J. (2002) Quick measurement of protein sulfhydryls with Ellman's reagent and with 4,4′-dithiodipyridine. Anal. Bioanal. Chem. 373, 266-276.
21. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
22. Sugio, S., Kashima, A., Mochizuki, S., Noda, M., and Kobayashi, K. (1999) Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng. 12, 439-446.
23. Pedretti, A., Villa, L., and Vistoli, G. (2002) VEGA: A versatile program to convert, handle and visualize molecular structure on windows-based PCs. J. Mol. Graph. 21, 47-49.
24. Porter, M. A., Hall, J. R., Locke, J. C., Jensen, J. H., and Molina, P. A. (2006) Hydrogen bonding is the prime determinant of carboxyl pKa values at the N-termini of alpha-helices. Proteins 63, 621-635.
25. Kalé, L., Skeel, R., Bhandarkar, M., Brunner, R., Gursoy, A., Krawetz, N., Phillips, J., Shinozaki, A., Varadarajan, K., and Schulten, K. (1999) NAMD2: Greater scalability for parallel molecular dynamics. J. Comp. Physiol. 151, 283-312.
26. McGann, M., Almond, H., Nicholls, A., Grant, J. A., and Brown, F. K. (2003) Gaussian docking functions. Biopolymers 68, 76-90.
27. Kinscherf, R., Cafaltzis, K., Röder, F., Hildebrandt, W., Edler, L., Deigner, H. P., Breitkreutz, R., Feussner, G., Kreuzer, J., Werle, E., Michel, G., Metz, J., and Dröge, W. (2003) Cholesterol levels linked to abnormal plasma thiol concentrations and thiol/disulfide redox status in hyperlipidemic subjects. Free Radical Biol. Med. 35, 1286-1292.
28. Andersson, A., Hutlberg, B., and Lindgren, A. (2000) Redox status of plasma homocysteine and other plasma thiols in stroke patients. Atherosclerosis 151, 535-539.
29. Carru, C., Deiana, L., Sotgia, S., Pes, G. M., and Zinellu, A. (2004) Plasma thiols redox status by laser-induced fluorescence capillary electrophoresis. Electrophoresis 25, 882-889.
30. Williams, R. H., Maggiore, J. A., Reynolds, R. D., and Helgason, C. M. (2001) Novel approach for the determination of the redox status of homocysteine and other aminothiols in plasma from healthy subjects and patients with ischemic stroke. Clin. Chem. 47, 1031-1039.
31. Doorn, J. A., and Petersen, D. R. (2002) Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal. Chem. Res. Toxicol. 15, 1445-1450.
32. Diaz, N., Suarez, D., and Sordo, T. L., Jr. (2001) A theoretical study of the aminolysis reaction of lysine 199 of human serum albumin with benzylpenicillin: Consequences for immunochemistry of penicillins. J. Am. Chem. Soc. 123, 7574-783.
33. Narazaki, R., Hamada, M., Harada, K., and Otagiri, M. (1996) Covalent binding between bucillamine derivatives and human serum albumin. Pharm. Res. 13, 1317-1321.
34. Stewart, A. J., Blindauer, C. A., Berezenko, S., Sleep, D., Tooth, D., and Sadler, P. J. (2005) Role of Tyr84 in controlling the reactivity of Cys34 of human albumin. FEBS J. 272, 353-362.
35. Patskovsky, Y., Patskovska, L., Almo, S. C., and Listowsky, I. (2006) Transition state model and mechanism of nucleophilic aromatic substitution reactions catalyzed by human glutathione S-transferase M1a-1a. Biochemistry 45, 3852-3862.
36. Links Surh, J., and Kwon, H. (2005) Estimation of daily exposure to 4-hydroxy-2-alkenals in Korean foods containing n-3 and n-6 polyunsaturated fatty acids. Food Addit. Contam. 22, 701-708.
37. Szapacs, M. E., Riggins, J. N., Zimmerman, L. J., and Liebler, D. C. (2006) Covalent adduction of human serum albumin by 4-hydroxy-2-nonenal: kinetic analysis of competing alkylation reactions. Biochemistry 45, 10521-10528.
38. Tallman, K. A., Kim, H. Y., Ji, J. X., Szapacs, M. E., Yin, H., McIntosh, T. J., Liebler, D. C., and Porter, N. A. (2007) Phospholipid-protein adducts of lipid peroxidation: Synthesis and study of new biotinylated phosphatidylcholines. Chem. Res. Toxicol. 20, 227-234.
39. Alary, J., Gueraud, F., and Cravedi, J. P. (2003) Fate of 4-hydroxynonenal in vivo: Disposition and metabolic pathways. Mol. Aspects Med. 24, 177-187.
40. Bennaars-Eiden, A., Higgins, L., Hertzel, A. V., Kapphahn, R. J., Ferrington, D. A., and Bernlohr, D. A. (2002) Covalent modification of epithelial fatty acid-binding protein by 4-hydroxynonenal in vitro and in vivo. Evidence for a role in antioxidant biology. J. Biol. Chem. 277, 50693-50702.
41. Wataya, T., Nunomura, A., Smith, M. A., Siedlak, S. L., Harris, P. L., Shimohama, S., Szweda, L. I., Kaminski, M. A., Avila, J., Price, D. L., Cleveland, D. W., Sayre, L. M., and Perry, G. (2002) High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal. J. Biol. Chem. 277, 4644-4648.
42. Pedersen, W. A., Chan, S. L., and Mattson, M. P. (2000) A mechanism for the neuroprotective effect of apolipoprotein E: Isoform-specific modification by the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 74, 1426-1433.
43. Aldini, G., Dalle-Donne, I., Vistoli, G., Maffei Facino, R., and Carini, M. (2005) Covalent modification of Actin by 4-hydroxy-trans-2-nonenal (HNE): LC-ESI-MS/MS evidence for Cys374 Michael adduction. J. Mass Spectrom. 40, 946-954.
44. Dalle-Donne, I., Carini, M., Vistoli, G., Gamberoni, L., Giustarini, D., Colombo, R., Maffei Facino, R., Rossi, R., Milzani, A., and Aldini, G. (2007) Actin Cys374 as a nucleophilic target of alpha,beta-unsaturated aldehydes. Free Radical Biol. Med. 42, 583-598.
45. Vaughn, M. W., Kuo, L., and Liao, J. C. (1998) Effective diffusion distance of nitric oxide in the microcirculation. Am. J. Physiol. 274, H1705-H1714.
46. Grune, T., Michel, P., Sitte, N., Eggert, W., Albrecht-Nebe, H., Esterbauer, H., and Siems, W. G. (1997) Increased levels of 4-hydroxynonenal modified proteins in plasma of children with autoimmune diseases. Free Radical Biol. Med. 23, 357-360.
47. Mak, S., Lehotay, D. C., Yazdanpanah, M., Azevedo, E. R., Liu, P. P., and Newton, G. E. (2000) Unsaturated aldehydes including 4-OH-nonenal are elevated in patients with congestive heart failure. J. Card. Failure 6, 108-114.
48. Sommerburg, O., Grune, T., Hampl, H., Riedel, E., van Kuijk, F. J., Ehrich, J. H., and Siems, W. G. (1998) Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients? Nephrol., Dial., Transplant. 13, 2583-2587.
49. Salomon, R. G., Kaur, K., Podrez, E., Hoff, H. F., Krushinsky, A. V., and Sayre, L. M. (2000) HNE-derived 2-pentylpyrroles are generated during oxidation of LDL, are more prevalent in blood plasma from patients with renal disease or atherosclerosis, and are present in atherosclerotic plaques. Chem. Res. Toxicol. 13, 557-564.
50. Lim, P. S., Cheng, Y. M., and Yang, S. M. (2007) Impairments of the biological properties of serum albumin in patients on haemodialysis. Nephrology (Carlton) 12, 18-24.
51. Terawaki, H., Yoshimura, K., Hasegawa, T., Matsuyama, Y., Negawa, T., Yamada, K., Matsushima, M., Nakayama, M., Hosoya, T., and Era, S. (1988) (2004) Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Kidney Int. 66, 1993.
52. Perna, A. F., Satta, E., Acanfora, F., Lombardi, C., Ingrosso, D., and De Santo, N. G. (2006) Increased plasma protein homocysteinylation in hemodialysis patients. Kidney Int. 69, 869-876.
53. Reusch, J. E., and Draznin, B. B. (2007) Atherosclerosis in diabetes and insulin resistance. Diabetes Obes. Metab. 9, 455-463.
54. Mera, K., Anraku, M., Kitamura, K., Nakajou, K., Maruyama, T., Tomita, K., and Otagiri, M. (2005) Oxidation and carboxy methyl lysine-modification of albumin: Possible involvement in the progression of oxidative stress in hemodialysis patients. Hypertens. Res. 28, 973-980.
55. Pennathur, S., and Heinecke, J. W. (2007) Mechanisms for oxidative stress in diabetic cardiovascular disease. Antioxid. Redox Signaling 9, 955-969.
56. Piwowar, A., Knapik-Kordecka, M., and Warwas, M. (2007) AOPP and its relations with selected markers of oxidative/antioxidative system in type 2 diabetes mellitus. Diabetes. Res. Clin. Pract. 77, 188-192.
57. Matteucci, E., Malvaldi, G., Fagnani, F., Evangelista, I., and Giampietro, O. (2004) Redox status and immune function in type I diabetes families. Clin. Exp. Immunol. 136, 549-554.
58. Faure, P., Troncy, L., Lecomte, M., Wiernsperger, N., Lagarde, M., Ruggiero, D., and Halimi, S. (2005) Albumin antioxidant capacity is modified by methylglyoxal. Diabetes Metab. 31, 169-77.
59. Zeng, J., and Davies, M. J. (2005) Evidence for the formation of adducts and S-(carboxymethyl)cysteine on reaction of α-dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins. Chem. Res. Toxicol. 18, 1232-1241.
60. Toyokuni, S., Yamada, S., Kashima, M., Ihara, Y., Yamada, Y., Tanaka, T., Hiai, H., Seino, Y., and Uchida, K. (2000) Serum 4-hydroxy-2-nonenal-modified albumin is elevated in patients with type 2 diabetes mellitus. Antioxid. Redox Signaling 2, 681-685.
61. Phillips, A., Shaper, A. G., and Whincup, P. H. (1989) Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet 2, 1434-1436.
62. Kuller, L. H., Eichner, J. E., Orchard, T. J., Grandits, G. A., McCallum, L., and Tracy, R. P. (1991) The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial. Am. J. Epidemiol. 134, 1266-1277.